14-day Premium Trial Subscription Try For FreeTry Free
Currently predicting for Mon, 17 Jun 2024

Trading levels for NVAX

Fibonacci Support & Resistance Levels

Level Price
R3 15.65 8.70%
R2 15.12 5.02%
R1 14.79 2.74%
Price 14.40
S1 13.73 -4.64%
S2 13.40 -6.91%
S3 12.87 -10.60%

Accumulated Volume Support & Resistance Levels

Level Price
R3 16.01 11.15%
R2 15.70 9.03%
R1 15.52 7.74%
Price 14.40
S1 13.48 -6.39%
S2 13.11 -8.96%
S3 12.90 -10.42%

NVAX Predictions History

4 years ago
JS predicted that NVAX for 2020-05-04 is going $16.53 (-8.47%)

4 years ago
Samir Sohail predicted that NVAX for 2020-05-04 is going

Rank:

4 years ago
JS predicted that NVAX for 2020-04-20 is going $19.82 (-16.72%)

4 years ago
Samir Sohail predicted that NVAX for 2020-04-20 is going

Rank:

4 years ago
ericrichardson151343 predicted that NVAX for 2020-04-13 is going

Rank:

4 years ago
2poJeff predicted that NVAX for 2020-04-13 is going $17.11 (0.35%)

4 years ago
JS predicted that NVAX for 2020-04-08 is going $14.21 (-17.29%)

4 years ago
Dante Jamal Hicks predicted that NVAX for 2020-04-08 is going $16.33 (9.60%)

Rank:

4 years ago
JS predicted that NVAX for 2020-04-03 is going $13.78 (-11.72%)

4 years ago
JS predicted that NVAX for 2020-03-31 is going $16.06 (18.26%)

Click to get the best stock tips daily for free!

About Novavax Inc

Novavax Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; NanoFlu, a nanoparticle seasonal quadrivalent influenza vaccine candidate that is in Phase 3 clinical tria... NVAX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT